Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125409611 | 12540961 | 1 | I | 20160630 | 20160630 | 20160708 | 20160708 | PER | US-ACTELION-A-US2016-138969 | ACTELION | 81.00 | YR | E | F | Y | 0.00000 | 20160708 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125409611 | 12540961 | 1 | PS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 4X DAILY | 21779 | INHALATION VAPOUR, SOLUTION | |||||||||
125409611 | 12540961 | 2 | SS | OPSUMIT | MACITENTAN | 1 | Oral | 10 MG, QD | 204410 | 10 | MG | TABLET | QD | ||||||
125409611 | 12540961 | 3 | C | RIOCIGUAT | RIOCIGUAT | 1 | 1 MG, TID | U | 0 | 1 | MG | TID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125409611 | 12540961 | 1 | Pulmonary arterial hypertension |
125409611 | 12540961 | 2 | Pulmonary arterial hypertension |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125409611 | 12540961 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125409611 | 12540961 | 1 | 20130206 | 0 | ||
125409611 | 12540961 | 2 | 20150528 | 0 | ||
125409611 | 12540961 | 3 | 20160122 | 0 |